v3.26.1
Stockholders’ Equity (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Stockholders’ Equity (Tables) [Line Items]    
Schedule of Assumptions Used for Options Granted

The assumptions used for options granted during the three months ended March 31, 2026, are as follows:

 

   March 31,
2026
 
Exercise Price   $9.00 - $12.00 
Expected dividends   0%
Expected volatility   322.65% - 322.83%
Risk free interest rate   4.04% - 4.30%
Expected life of option   10 years 

The assumptions used for options granted during the year ended December 31, 2025 and 2024, are as follows:

 

   December 31,
2025
 
Exercise Price   $5.00 - $7.40 
Expected dividends   0%
Expected volatility   363.00% - 366.01%
Risk free interest rate   4.04% - 4.57%
Expected life of option   10 years 

 

   December 31,
2024
 
Exercise Price   $35.60 - $38.40 
Expected dividends   0%
Expected volatility   215.44% - 218.11%
Risk free interest rate   4.17% - 4.69%
Expected life of option   10 years 
Schedule of the Stock Option Activity

The following is a summary of the Company’s stock option activity:

 

   Options   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
Balance – December 31, 2025 – outstanding   569,922   $36.05    9.06 
Granted   1,093,500   $9.88    9.84 
Exercised   
-
   $
-
    
-
 
Forfeited/Cancelled   
-
   $
-
    
-
 
Expired   (7)  $124,671.43    
-
 
Balance – March 31, 2026 – outstanding   1,663,415   $20.45    6.47 
Balance – March 31, 2026 – exercisable   1,087,500   $30.15    9.84 

The following is a summary of the Company’s stock option activity:

 

   Options   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
Balance – December 31, 2024 – outstanding   103,679   $178.60    8.84 
Granted   466,243   $4.34    10.00 
Exercised   -    -    - 
Forfeited/Cancelled   -    -    - 
Balance – December 31, 2025 – outstanding   569,922   $36.05    9.06 
Balance – December 31, 2025 – exercisable   557,277   $34.96    9.04 
Schedule of Warrants Outstanding and Warrants Exercisable
Option Outstanding   Option Exercisable 
Weighted
Average
Exercise Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
Life
(in years)
   Weighted
Average
Exercise Price
   Number
Exercisable
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
$20.45    1,663,415    6.47   $30.15    1,087,500    9.84 
Option Outstanding   Option Exercisable 
Weighted
Average
Exercise Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
Life
(in years)
   Weighted
Average
Exercise Price
   Number
Exercisable
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
$36.05    569,922    9.06   $34.96    557,277    9.04 
Schedule of Warrants Granted

The assumptions used for warrants granted during the three months ended March 31, 2026, are as follows:

 

   March 31,
2026
 
Exercise Price  $10.00 
Expected dividends   %
Expected volatility   197.79% - 197.90%
Risk free interest rate   3.61% - 3.82%
Expected life of warrants   5 years 

The assumptions used for warrants granted during the year ended December 31, 2025, are as follows:

 

   December 31,
2025
 
Exercise Price   $6.80 - 24.00 
Expected dividends   0%
Expected volatility   196.11% - 279.01%
Risk free interest rate   3.57% - 4.45%
Expected life of warrants   5 years 

 

   December 31,
2024
 
Exercise Price   $5.20 - 140.00 
Expected dividends   0%
Expected volatility   201.06% - 309.08%
Risk free interest rate   3.41% - 4.66%
Expected life of warrants   5 years 
Warrant Activities [Member]    
Stockholders’ Equity (Tables) [Line Items]    
Schedule of the Stock Option Activity

The following is a summary of the Company’s warrant activity: 

 

   Warrants   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
Balance – December 31, 2025 – outstanding   2,401,378   $12.51    3.55 
Granted   60,594   $10.00    5.00 
Exercised   
   $
    
 
Forfeited/Cancelled   
   $
    
 
Balance – March 31, 2026 – outstanding   2,461,972   $12.45    3.34 
Balance – March 31, 2026 – exercisable   2,461,972   $12.45    3.34 

The following is a summary of the Company’s warrant activity: 

 

   Warrants   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
Balance – December 31, 2024 – outstanding   1,310,343   $8.00    3.64 
Granted   1,183,367   $14.71    5.00 
Exercised   (92,043)  $5.14    - 
Forfeited/Cancelled   (290)  $2,363    - 
Balance – December 31, 2025 – outstanding   2,401,378   $6.73    3.55 
Balance – December 31, 2025 – exercisable   2,401,378   $6.73    3.55 
Schedule of Warrants Outstanding and Warrants Exercisable
Warrants Outstanding   Warrants Exercisable 
Weighted
Average
Exercise Price
   Number
Outstanding
   Weighted
Average
Remaining
Contractual
Life
(in years)
   Weighted
Average
Exercise Price
   Number
Exercisable
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
$12.45    2,461,972    3.34   $12.45    2,461,972    3.34 
Warrants Outstanding     Warrants Exercisable  
Weighted
Average
Exercise Price
    Number
Outstanding
    Weighted
Average
Remaining
Contractual
Life
(in years)
    Weighted
Average
Exercise Price
    Number
Exercisable
    Weighted
Average
Remaining
Contractual
Life
(in years)
 
$ 6.73       2,401,378       3.55     $ 6.73       2,401,378       3.55